FDA NEWS

New Medical Products: FDA Licenses New Hemophilia Treatment
FDA recently licensed a new treatment for hemophilia A called Xyntha. Xyntha, which is made by Wyeth Pharmaceuticals, is a genetically engineered version of factor VIII, a protein essential for blood clotting that is decreased or absent in patients ...

Preventing Medical Errors: Mistakenly Swallowing Inhaler Capsules
FDA has issued an advisory about the danger of mistakenly swallowing Spiriva (tiotropium bromide inhalation powder) and Foradil (formoterol fumarate inhalation powder) inhalation capsules. These capsules are intended to be used with inhalation devic...

Recalls and Safety Alerts: Unsafe Use of Extended-Release Tussionex Suspension
FDA is cautioning healthcare professionals, patients and caregivers about the unsafe use of Tussionex Pennkinetic Extended-Release Suspension. This product is a long-acting cough suppressant containing hydrocodone, a narcotic antitussive, and chlorp...

Resolved Drug Shortage: Lymphazurin 1% injection (isosulfan blue)
Covidien now has Lymphazurin 1% injection available.

Drug to be Discontinued: Geocillin (carbenicillin indanyl sodium) tablets 382 mg
Pfizer has discontinued this product. There are no other FDA approved manufacturers currently for carbenicillin tablets.

Drug to be Discontinued: Tilade Inhaler (nedocromil sodium inhalation aerosol)
Dear Healthcare Professional Letter is available.

Trasylol (aprotinin injection)
Bayer Pharmaceuticals notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.

Current Drug Shortage: Neupro (rotigotine transdermal system)
UCB is preparing to recall all Neupro lots in the U.S. by May 2008

Labels: FDA